Healixa, Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)
Healixa, Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)
ORLANDO, FL / ACCESSWIRE / August 26, 2022 / RedChip Companies will air a new interview with Healixa, Inc. (OTC Pink:EMOR) ("Healixa," or the "Company"), a technology company focusing on building and acquiring innovative and disruptive technologies in the health-tech, clean water, and green-tech industries, on The RedChip Money Report® on Bloomberg TV, this Saturday, August 27, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.
佛羅裏達州奧蘭多/ACCESSWIRE/2022年8月26日/紅籌公司將於8月27日週六晚7點在彭博電視臺播出對Healixa，Inc.(場外交易粉色代碼：EMOR)的新一輪採訪，Healixa，Inc.是一家專注於在健康技術、清潔水和綠色技術行業建立和獲取創新和顛覆性技術的技術公司。東部時間(ET)。據估計，全美約有7300萬個家庭可以收看彭博電視。
Interview highlights:
採訪亮點：
In the exclusive RedChip Money Report interview, Healixa's CEO Ian Parker discusses the Company's innovative atmospheric water harvesting system, their IP portfolio, the multi-billion dollar market opportunity, and much more.
在RedChip Money Report獨家訪談中，Healixa的首席執行官Ian Parker討論了該公司的創新大氣集水系統、他們的IP組合、數十億美元的市場機會等。
Access this interview in its entirety at
訪問此訪談全文，請訪問
About The RedChip Money Report®
關於紅籌資金報告®
The RedChip Money Report® is produced by RedChip Companies Inc., an international Investor Relations and media firm with 30 years' experience focused on Discovering Tomorrow's Blue Chips Today™. "The RedChip Money Report®" delivers insightful commentary on small-cap investing, interviews with Wall Street analysts, financial book reviews, as well as featured interviews with executives of public companies.
紅籌資金報告®由紅籌公司製作，該公司是一家國際投資者關係和媒體公司，擁有30年的經驗，專注於今天發現明天的藍籌股™.《紅籌資金報告》(The RedChip Money Report®)提供了關於小盤股投資的精闢評論、華爾街分析師的採訪、金融書評以及對上市公司高管的專題採訪。
About Healixa, Inc.
Healixa公司簡介
Healixa is a technology company focusing on building and acquiring innovative and disruptive technologies in the health-tech, clean water generation and green-tech industries. Healixa embraces innovation by combining its intellectual properties, patents, strategic collaborations, and partnerships to create a "LaunchPad" of disruptive sustainable products. For more information, visit .
Healixa是一家科技公司，專注於在健康科技、清潔水發電和綠色科技行業建立和收購創新和顛覆性技術。Healixa擁抱創新，將其知識產權、專利、戰略合作和合作夥伴關係結合在一起，創建了一個顛覆性可持續產品的“發射臺”。有關更多信息，請訪問。
About RedChip Companies
關於紅籌公司
RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on microcap and small-cap companies. For 30 years, RedChip has delivered concrete, measurable results for its clients. Our newsletter, the RedChip Money Report is delivered online weekly to 60,000 investors. RedChip has developed the most comprehensive service platform in the industry for microcap and small-cap companies. These services include the following: a worldwide distribution network for its stock research; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated millions of unique investor views; investor webinars and group calls; a television show, "The RedChip Money Report," which airs weekly on Bloomberg US; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more.
紅籌公司是一家擁有5000美元股份的公司，是一家專注於微市值和小盤股公司的國際投資者關係、媒體和研究公司。30年來，紅籌為客户提供了具體、可衡量的結果。我們的時事通訊《紅籌資金報告》每週在線發送給60,000名投資者。紅籌為小盤股和小盤股公司開發了業內最全面的服務平臺。這些服務包括：其股票研究的全球分銷網絡；在美國主要城市的零售和機構路演；面向股票經紀人、RIA、機構和家族理財室的對外營銷；已產生數百萬獨特投資者觀點的數字媒體投資者關係平臺；投資者網絡研討會和團體電話會議；每週在彭博美國播出的電視節目“紅籌資金報告”；本地和全國市場的電視廣告；企業和產品視頻；網站設計；以及傳統投資者關係服務，其中包括新聞稿撰寫、投資者演示文稿的開發、季度電話會議腳本編寫、戰略諮詢、融資等。
To learn more about RedChip's products and services, please visit:
要了解更多有關紅籌公司產品和服務的信息，請訪問：
"Discovering Tomorrow's Blue Chips Today"™
《今日發現明天的藍籌股》™
Safe Harbor Statement
安全港聲明
Certain statements contained in this press release may constitute forward-looking statements. For example, forward-looking statements are used when discussing our expected research and development programs, and more. These forward-looking statements are based only on current expectations of management and are subject to significant risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements, including but not limited to the risks and uncertainties related to the progress, timing, cost, and results of Partnerships and product development programs; difficulties or delays in obtaining regulatory approval or patent protection; and competition from other companies. Except as otherwise required by law, Healixa, Inc. undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
本新聞稿中包含的某些陳述可能構成前瞻性陳述。例如，在討論我們預期的研發計劃等時，會使用前瞻性陳述。這些前瞻性陳述僅基於對管理層的當前預期，受重大風險和不確定因素的影響，這些風險和不確定因素可能導致實際結果與前瞻性陳述中描述的大不相同，包括但不限於與合作伙伴關係和產品開發計劃的進度、時間、成本和結果有關的風險和不確定因素；在獲得監管批准或專利保護方面的困難或延遲；以及來自其他公司的競爭。除非法律另有要求，Healixa，Inc.沒有義務公開發布對這些前瞻性陳述的任何修訂，以反映本前瞻性陳述之後的事件或情況，或反映意外事件的發生。
Contact:
聯繫方式：
Dave Gentry
RedChip Companies Inc.
1-800-RED-CHIP (733-2447)
Or 407-491-4498
EMOR@redchip.com
戴夫·金特里
紅籌公司。
1-800-紅籌(733-2447)
或407-491-4498
郵箱：Emor@redchip.com
SOURCE: RedChip Companies Inc.
資料來源：紅籌公司。
譯文內容由第三人軟體翻譯。